Provided by Tiger Fintech (Singapore) Pte. Ltd.

CASI Pharmaceuticals

2.23
+0.15507.49%
Post-market: 2.230.00000.00%18:12 EDT
Volume:7.55K
Turnover:16.79K
Market Cap:34.47M
PE:-1.00
High:2.40
Open:2.04
Low:2.04
Close:2.07
Loading ...
Aug 26, 2023

Correspondence

Form CORRESP - Correspondence
Jun 23, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 23, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 26, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 21, 2023

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 21, 2023

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 21, 2023

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 21, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Correspondence

CORRESP [Cover] - Correspondence